Publications
5808 Results
- Journal / Conference
- San Antonio Breast Cancer Symposium Annual Meeting (December 9-13, 2014, San Antonio, TX), abstr. [OT2-1-01], poster;
- Year
- 2014
- Research Committee(s)
- Breast
- Study Number(s)
- S1222
Fulvestrant alone versus fulvestrant and everolimus versus fulvestrant, everolimus and anastrozole: A Phase III randomized, placebo-controlled trial in postmenopausal patients with hormone-receptor-positive stage IV breast cancer: SWOG-Clinical Trials Initiative (CTI)* S1222
- Journal / Conference
- Clinical Cancer Research 20(16):4176-4185;
- Year
- 2014
- Research Committee(s)
- Gastrointestinal
- PMID
- PMID24914040
- PMC
- PMC4296727
- Study Number(s)
- S0107, S0205, SWOG-8916, SWOG-8933, SWOG-9100, SWOG-9135, SWOG-9413, S9629, S9924
Historical controls for metastatic pancreatic cancer: benchmarks for planning and analyzing single arm phase II trials
- Journal / Conference
- Journal of Clinical Oncology Vol 32, No 26_suppl, 2014: 36; ASCO Breast Cancer Symposium (September 4-6, 2014, San Francisco, CA);
- Year
- 2014
- Research Committee(s)
- Breast
Recurrence score and clinicopathologic characteristics of TAILORx participants by race and ethnicity
- Journal / Conference
- Journal of Clinical Oncology 32(18):1927-1934
- Year
- 2014
- Research Committee(s)
- Gastrointestinal
- PMID
- PMID24799484
- PMC
- PMC4050205
Capecitabine and oxaliplatin in the preoperative multi-modality treatment of rectal cancer: surgical end points from national surgical adjuvant breast and bowel project trial R-04
- Journal / Conference
- Cancer Epidemiology, Biomarkers and Prevention 23(12):2895-2905;
- Year
- 2014
- Research Committee(s)
- Prevention, Screening, and and Surveillance
- PMID
- PMID25242051
- PMC
- PMC4257858
- Study Number(s)
- S0000
Retention of black and white participants in the Selenium and Vitamin E Cancer Prevention Trial (SWOG-Coordinated Intergroup Study S0000)
- Journal / Conference
- Journal of Urology Vol. 191, No. 4S, Suppl., p. e283 (PD10-04); poster; American Urological Assn Annual Meeting (May 16 -21, 2014, Orlando, FL);
- Year
- 2014
- Research Committee(s)
- Genitourinary
- Study Number(s)
- CTSU/E2805
Lymphadenectomy at the time of surgery for high risk localized RCC: results from the ASSURE adjuvant trial (ECOG 2805)
- Journal / Conference
- Journal of Clinical Oncology 32(suppl 4; abstr LBA287), oral; ASCO GU Cancers Symposium
- Year
- 2014
- Research Committee(s)
- Genitourinary
- Study Number(s)
- CTSU/R0524
The initial report of RTOG 0524: Phase I/II trial of a combination of paclitaxel and trastuzumab with daily irradiation or paclitaxel alone with daily irradiation following transurethral surgery for noncystectomy candidates with muscle-invasive bladder cancer
- Journal / Conference
- Radiotherapy and Oncology 112(3):418-424;
- Year
- 2014
- Research Committee(s)
- Gastrointestinal
- PMID
- PMID24996454
- PMC
- PMC4258107
- Study Number(s)
- S0713
Consequences of anorectal cancer atlas implementation in the cooperative group setting: radiobiologic analysis of a prospective randomized in silico target delineation study
- Journal / Conference
- Annals of Oncology 25 (Suppl 4): iv1 - mdu438.66; ESMO 2014 Congress (Sept 26-30, 2014, Madrid, Spain), oral presentation;
- Year
- 2014
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- CTSU/C80405
CALGB/SWOG C80405: PHASE III trial of irinotecan/5-FU/leucovorin (FOLFIRI) or oxaliplatin/5-FU/leucovorin (mFOLFOX6) with bevacizumab (BV) or cetuximab (CET) for patients (pts) with expanded ras analyses untreated metastatic adenocarcinoma of the colon or rectum (MCRC)
- Journal / Conference
- Annals of Oncology 25 (Suppl 4): iv1 - mdu438.66; ESMO 2014 Congress (September 26-30, 2014, Madrid, Spain), poster presentation;
- Year
- 2014
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- CTSU/C80702